Hamilton Lane Incorporated HLNE
94.99 USD +6.36 (+7.18%)
At closeNov 4, 2026, 5:30 PM EST
94.99 0.00 0.00%
After hours · Nov 4, 5:30 PM ET
90.91 Day range 95.15
71.88 52-week range 155.66
- YTD
- -29.28%
- 1 year
- -22.31%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 123.13 +29.6% upside
Now 94.99
- Target (low)
- 95.00
- Target (mean)
- 123.13
- Target (high)
- 171.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
- Strong buy2
- Buy5
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 7
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.72 | 1.33 – 2.09 | 1.55 | +11.3% | 231.01M | +16.3% | 7 |
| Next quarter | 1.78 | 1.34 – 1.97 | 1.49 | +19.5% | 237.52M | +22.7% | 7 |
| Current year | 7.27 | 6.79 – 7.75 | 5.90 | +23.2% | 982.77M | +29.5% | 6 |
| Next year | 7.37 | 7.15 – 7.67 | 7.27 | +1.4% | 1.06B | +7.8% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 4, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 4, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Oct 27, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Oct 13, 2026 | UBS | Maintained | Buy | Buy |
| Oct 2, 2026 | Wells Fargo | Initiated | — | Overweight |
| Aug 27, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 5, 2026 | UBS | Maintained | Buy | Buy |
| Aug 5, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 5, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jul 21, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 17, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 10, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jun 30, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jun 18, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| May 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| May 22, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| May 18, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 21, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 16, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Apr 13, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 24, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 20, 2026 | UBS | Maintained | Buy | Buy |
| Feb 4, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 4, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jan 13, 2026 | UBS | Maintained | Buy | Buy |
| Jan 8, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Dec 17, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Nov 6, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Oct 21, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
